CIK 0001652130 · Large accelerated filer
Intellia Therapeutics, Inc.
Sign in to watch- Ticker
- NTLA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364785571
- Phone
- 857-285-6200
- Business address
- 400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $417,899
- in 3 filings, $395K under 10b5-1 plans
Net −$417,899. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 7 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-01 | LEONARD JOHN M President and CEO | Option exercise | +15,985 | $18.30 | $293K | 764,040 |
| 2021-09-01 | LEONARD JOHN M President and CEO | Sale | −44,735 | $170.00 | $7.6M | 719,305 |
| 2021-09-01 | LEONARD JOHN M President and CEO | Option exercise · Stock Option (right to buy) | −28,750 | 0 | ||
| 2021-09-01 | LEONARD JOHN M President and CEO | Option exercise · Stock Option (right to buy) | −15,985 | 11,515 | ||
| 2021-08-31 | LEONARD JOHN M President and CEO | Option exercise | +37,833 | $14.58 | $552K | 757,138 |
| 2021-08-31 | LEONARD JOHN M President and CEO | Sale | −37,833 | $155.00 | $5.9M | 719,305 |
| 2021-08-31 | LEONARD JOHN M President and CEO | Option exercise · Stock Option (right to buy) | −37,833 | 90,000 | ||
| 2021-08-31 | Goddard Glenn EVP, Chief Financial Officer | Option exercise | +22,983 | $19.27 | $443K | 22,983 |
| 2021-08-31 | Goddard Glenn EVP, Chief Financial Officer | Option exercise | +1,817 | $14.58 | $26K | 24,800 |
| 2021-08-31 | Goddard Glenn EVP, Chief Financial Officer | Sale | −24,800 | $160.22 | $4.0M | 0 |
| 2021-08-31 | Goddard Glenn EVP, Chief Financial Officer | Option exercise · Stock Option (right to buy) | −22,983 | 41,817 | ||
| 2021-08-31 | Goddard Glenn EVP, Chief Financial Officer | Option exercise · Stock Option (right to buy) | −1,817 | 15,933 | ||
| 2021-08-30 | LEONARD JOHN M President and CEO | Option exercise | +11,637 | $13.40 | $156K | 730,942 |
| 2021-08-30 | LEONARD JOHN M President and CEO | Option exercise | +27,167 | $14.58 | $396K | 758,109 |
| 2021-08-30 | LEONARD JOHN M President and CEO | Sale | −2,055 | $152.81 | $314K | 756,054 |
| 2021-08-30 | LEONARD JOHN M President and CEO | Sale | −2,334 | $153.66 | $359K | 753,720 |
| 2021-08-30 | LEONARD JOHN M President and CEO | Sale | −7,428 | $154.98 | $1.2M | 746,292 |
| 2021-08-30 | LEONARD JOHN M President and CEO | Sale | −15,567 | $155.70 | $2.4M | 730,725 |
| 2021-08-30 | LEONARD JOHN M President and CEO | Sale | −4,758 | $156.96 | $747K | 725,967 |
| 2021-08-30 | LEONARD JOHN M President and CEO | Sale | −3,123 | $157.75 | $493K | 722,844 |
Page 16 of 40 · 783 trades